Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States

Emerg Infect Dis. 2021 Jan;27(1):140-149. doi: 10.3201/eid2701.190676.

Abstract

Provision of safe drinking water in the United States is a great public health achievement. However, new waterborne disease challenges have emerged (e.g., aging infrastructure, chlorine-tolerant and biofilm-related pathogens, increased recreational water use). Comprehensive estimates of the health burden for all water exposure routes (ingestion, contact, inhalation) and sources (drinking, recreational, environmental) are needed. We estimated total illnesses, emergency department (ED) visits, hospitalizations, deaths, and direct healthcare costs for 17 waterborne infectious diseases. About 7.15 million waterborne illnesses occur annually (95% credible interval [CrI] 3.88 million-12.0 million), results in 601,000 ED visits (95% CrI 364,000-866,000), 118,000 hospitalizations (95% CrI 86,800-150,000), and 6,630 deaths (95% CrI 4,520-8,870) and incurring US $3.33 billion (95% CrI 1.37 billion-8.77 billion) in direct healthcare costs. Otitis externa and norovirus infection were the most common illnesses. Most hospitalizations and deaths were caused by biofilm-associated pathogens (nontuberculous mycobacteria, Pseudomonas, Legionella), costing US $2.39 billion annually.

Keywords: Campylobacter; Cryptosporidium; Giardia; Legionella; Pseudomonas; Salmonella; Shiga toxin-producing Escherichia coli; Shigella; United States; Vibrio; bacteria; burden of disease; cost of illness; nontuberculous mycobacteria; norovirus; otitis externa; viruses; waterborne.

MeSH terms

  • Communicable Diseases* / epidemiology
  • Health Care Costs
  • Hospitalization
  • Humans
  • United States / epidemiology
  • Water Microbiology
  • Waterborne Diseases* / epidemiology